Tvardi Therapeutics TVRD
NASDAQ TVRD
$0.94 -0.05 (-4.57%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tvardi Therapeutics (TVRD) Cash & Current Investments (2013 - 2026)

Updated

Tvardi Therapeutics' Cash & Current Investments was $15.8 million in Q2 2026, down 61.5% from $40.99 million a year earlier and down 36.9% from the prior quarter.

Analysis

Tvardi Therapeutics (TVRD) Cash & Current Investments (2013 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Tvardi Therapeutics came in at $30.81 million, down 2.5% from FY2024.

  • Cash & Current Investments has now declined for five consecutive years, with a five-year compound annual growth rate of -29.8% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $31.61 million in FY2024 (-68.6%), $100.76 million in FY2023 (-30.7%), $145.4 million in FY2022 (-13.0%) and $167.04 million in FY2021 (-7.7%).
  • The Q2 2026 figure marks the lowest quarterly Cash & Current Investments since Q4 2013.
  • Compared with a year earlier, Cash & Current Investments has declined for 15 straight quarters, with an average decline of 37.2% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q3 2021 (growth of 19.3%); the worst was Q4 2024 (a decline of 68.6%).
  • Per Business Quant data, TVRD's Cash & Current Investments in the three quarters before Q2 2026 was $25.03 million (Q1 2026), $30.81 million (Q4 2025) and $36.46 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Tvardi Therapeutics 8.82 Mn -99.28 Mn - 15.80 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.80 Mn
Mar 31, 2026 25.03 Mn
Dec 31, 2025 30.81 Mn
Sep 30, 2025 36.46 Mn
Jun 30, 2025 40.99 Mn
Mar 31, 2025 34.22 Mn
Dec 31, 2024 31.61 Mn
Sep 30, 2024 42.04 Mn
Jun 30, 2024 56.62 Mn
Mar 31, 2024 69.77 Mn
Dec 31, 2023 100.76 Mn
Sep 30, 2023 78.54 Mn
Jun 30, 2023 94.69 Mn
Mar 31, 2023 114.28 Mn
Dec 31, 2022 145.40 Mn
Sep 30, 2022 155.61 Mn
Jun 30, 2022 157.51 Mn
Mar 31, 2022 141.11 Mn
Dec 31, 2021 167.04 Mn
Sep 30, 2021 144.19 Mn
API Access

Tvardi Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=TVRD&period=max&api_key=YOUR_API_KEY